SEC 13F Intelligence

Managers / Q2 2024

Kent Lake Capital LLC

CIK 0001777141 · 1 E LIBERTY ST, STE 600 #1025, RENO, NV, 89501 · 4157992720

Reported Value
$222M
Q2 2024
Positions
44
Filings on Record
16
2019–present window
Filed
Aug 14, 2024
original filing

Summary

Kent Lake Capital LLC reported $222M in U.S.-listed holdings across 44 positions for Q2 2024.

Its largest position, ZIMV, represents 10.3% of the portfolio.

Compared with Q1 2024, the fund opened 16 new positions and exited 15.

Portfolio Metrics

Turnover
+40.1%
vs prior filed quarter
Top-10 Concentration
+49.1%
share of reported value
Largest Position
+10.3%
Zimvie
New / Exited
16 / 15
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’20: $211MQ4 ’20Q1 ’21: $246MQ2 ’21: $261MQ2 ’21Q3 ’21: $233MQ4 ’21: $193MQ4 ’21Q1 ’22: $161MQ2 ’22: $182MQ2 ’22Q3 ’22: $153MQ4 ’22: $167MQ4 ’22Q1 ’23: $148MQ2 ’23: $218MQ2 ’23Q3 ’23: $260MQ4 ’23: $259MQ4 ’23Q1 ’24: $229MQ2 ’24: $222MQ2 ’24filingsflow.com

Portfolio Composition

By security type
Common Stock: 91.4%Other: 8.6%
  • Common Stock · 91.4% · $203M
  • Other · 8.6% · $19M

Quarter-over-Quarter Changes full breakdown →

vs Q1 2024 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
TALKTALKSPACE INCNEW+4.00M4.00M+$9M$9M
ATRCATRICURE INCNEW+250.0K250.0K+$6M$6M
NVROEURNEVRO CORPNEW+639.8K639.8K+$5M$5M
AHCOADAPTHEALTH CORPNEW+500.0K500.0K+$5M$5M
TMCITREACE MED CONCEPTS INCNEW+750.0K750.0K+$5M$5M
EB4EVENTBRITE INCNEW+1.00M1.00M+$5M$5M
ANGOANGIODYNAMICS INCNEW+750.0K750.0K+$5M$5M
UPWKUPWORK INCNEW+300.0K300.0K+$3M$3M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q2 2024

44 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1ZIMVZIMVIE INChistory →COM10.29%$23M1.25M
2KDKYNDRYL HLDGS INChistory →COMMON STOCK5.93%$13M500.0K
3SIBNSI-BONE INChistory →COM4.66%$10M800.0K
4ENSGENSIGN GROUP INChistory →COM4.46%$10M80.0K
5PNTGPENNANT GROUP INChistory →COM4.44%$10M425.0K
6TALKTALKSPACE INChistory →COM4.15%$9M4.00M
7INNVINNOVAGE HLDG CORPhistory →COM3.95%$9M1.77M
8NPCENEUROPACE INChistory →COM3.90%$9M1.14M
9UEICUNIVERSAL ELECTRS INChistory →COM3.71%$8M708.9K
10EHABUSDENHABIT INChistory →COM3.55%$8M883.8K
11VMDVIEMED HEALTHCARE INChistory →COM3.36%$7M1.14M
12FIVERR INTL LTDORD SHS3.17%$7M300.0K
13ADVANTAGE SOLUTIONS INCCOM CL A2.71%$6M1.87M
14CCSICONSENSUS CLOUD SOLUTIONS INhistory →COM2.63%$6M340.0K
15ATRCATRICURE INChistory →COM2.57%$6M250.0K
16VMEO*VIMEO INChistory →COMMON STOCK2.52%$6M1.50M
17NVROEURNEVRO CORPhistory →COM2.43%$5M639.8K
18LUCKBOWLERO CORPhistory →CL A COM2.29%$5M350.0K
19AHCOADAPTHEALTH CORPhistory →COMMON STOCK2.25%$5M500.0K
20TMCITREACE MED CONCEPTS INChistory →COM2.25%$5M750.0K
21EB4EVENTBRITE INChistory →COM CL A2.18%$5M1.00M
22SILICOM LTDORD2.15%$5M315.0K
23VCELVERICEL CORPhistory →COM2.07%$5M100.0K
24ANGOANGIODYNAMICS INChistory →COM2.05%$5M750.0K
25CDXSCODEXIS INChistory →COM1.82%$4M1.30M
26UPWKUPWORK INChistory →COM1.45%$3M300.0K
27EGHT8X8 INC NEWhistory →COM1.45%$3M1.45M
28STIMNEURONETICS INChistory →COM1.41%$3M1.74M
29OABIOMNIAB INChistory →COM1.35%$3M800.0K
30INGNINOGEN INChistory →COM1.06%$2M289.7K
31LUNGPULMONX CORPCOM0.94%$2M328.3K
32EBSEMERGENT BIOSOLUTIONS INCCOM0.92%$2M300.0K
33ATROASTRONICS CORPCOM0.90%$2M100.0K
34SKIN2EURTHE BEAUTY HEALTH COMPANYCOM CL A0.84%$2M970.8K
35XEJACCURAY INCCOM0.82%$2M1.00M
36XPELXPEL INCCOM0.56%$1M34.9K
37REWALK ROBOTICS LTDSHS0.52%$1M287.3K
38QTRXQUANTERIX CORPCOM0.45%$990,75075.0K
39SEERSEER INCCOM CL A0.38%$840,000500.0K
40TOITHE ONCOLOGY INSTITUTE INCCOM0.36%$805,0001.75M
41AVNWAVIAT NETWORKS INCCOM NEW0.34%$746,54226.0K
42EKSO BIONICS HLDGS INCCOM0.33%$734,333696.0K
43HHSHARTE HANKS INCCOM0.20%$449,01255.3K
44ORGOORGANOGENESIS HLDGS INCCOM0.19%$425,334151.9K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q2 2024$222M44Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$229M43May 15, 202413F-HRchanges · EDGAR ↗
Q4 2023$259M47Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$260M52Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$218M50Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$148M35May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$167M38Feb 14, 202313F-HRchanges · EDGAR ↗
Q3 2022$153M37Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$182M47Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$161M39May 16, 202213F-HRchanges · EDGAR ↗
Q4 2021$193M37Feb 14, 202213F-HRchanges · EDGAR ↗
Q3 2021$233M31Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$261M28Aug 16, 202113F-HRchanges · EDGAR ↗
Q1 2021REVEALED$246M30May 17, 202113F-HRchanges · EDGAR ↗
Q4 2020$211M32Feb 12, 202113F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.